1. Home
  2. RGNX vs ATNI Comparison

RGNX vs ATNI Comparison

Compare RGNX & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • ATNI
  • Stock Information
  • Founded
  • RGNX 2008
  • ATNI 1987
  • Country
  • RGNX United States
  • ATNI United States
  • Employees
  • RGNX N/A
  • ATNI N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • ATNI Telecommunications Equipment
  • Sector
  • RGNX Health Care
  • ATNI Telecommunications
  • Exchange
  • RGNX Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • RGNX 387.0M
  • ATNI 328.8M
  • IPO Year
  • RGNX 2015
  • ATNI 1991
  • Fundamental
  • Price
  • RGNX $6.76
  • ATNI $20.27
  • Analyst Decision
  • RGNX Strong Buy
  • ATNI Strong Buy
  • Analyst Count
  • RGNX 9
  • ATNI 2
  • Target Price
  • RGNX $32.89
  • ATNI $31.00
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • ATNI 93.2K
  • Earning Date
  • RGNX 05-07-2025
  • ATNI 03-04-2025
  • Dividend Yield
  • RGNX N/A
  • ATNI 4.73%
  • EPS Growth
  • RGNX N/A
  • ATNI N/A
  • EPS
  • RGNX N/A
  • ATNI N/A
  • Revenue
  • RGNX $83,328,000.00
  • ATNI $729,075,000.00
  • Revenue This Year
  • RGNX $285.14
  • ATNI $3.02
  • Revenue Next Year
  • RGNX N/A
  • ATNI $0.27
  • P/E Ratio
  • RGNX N/A
  • ATNI N/A
  • Revenue Growth
  • RGNX N/A
  • ATNI N/A
  • 52 Week Low
  • RGNX $5.62
  • ATNI $14.74
  • 52 Week High
  • RGNX $21.19
  • ATNI $33.72
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • ATNI 49.75
  • Support Level
  • RGNX $7.96
  • ATNI $20.94
  • Resistance Level
  • RGNX $8.35
  • ATNI $22.23
  • Average True Range (ATR)
  • RGNX 0.65
  • ATNI 1.14
  • MACD
  • RGNX -0.04
  • ATNI -0.31
  • Stochastic Oscillator
  • RGNX 13.21
  • ATNI 9.02

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.

Share on Social Networks: